Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Biotechnology
Biotechnology
Health
23andMe users are being urged to delete their data. Here’s how to do it
By
Alexa Mikhail
and
Beth Greenfield
March 24, 2025
Commentary
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By
Michelle Werner
March 10, 2025
Leadership
A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By
Lila MacLellan
March 1, 2025
Health
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By
Lindsey Leake
January 16, 2025
Arnold Schwarzenegger is joining a Fortune 500 company to solve a great problem of his generation
By
Lindsey Leake
November 13, 2024
Health
How to delete your DNA data from 23andMe
By
Alexa Mikhail
October 5, 2024
Tech
Meta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream
By
Sharon Goldman
June 25, 2024
Commentary
I’ve been practicing medicine at a renowned institution for 40 years. Society isn’t ready for us to reverse the aging process across an entire population
By
Joel Geiderman
June 20, 2024
Life
A 45-year-old tech CEO is spending millions a year to be 18 again—even though his doctor admits the results are minimal
By
Alexa Mikhail
January 26, 2023
Finance
Biden’s new executive order triggers new front in U.S.-China economic competition
By
Tristan Bove
September 12, 2022
Newsletters
At financial software giant Intuit, A.I. is becoming ‘foundational’ to how the company operates
By
Jeremy Kahn
August 26, 2022
Newsletters
A.I. is rapidly transforming biological research—with big implications for everything from drug discovery to agriculture to sustainability
By
Jeremy Kahn
July 28, 2022
Magazine
Moderna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?
By
Rey Mashayekhi
December 2, 2021
Newsletters
What’s big in A.I. this year
By
Jeremy Kahn
October 12, 2021
Tech
DeepMind unveils how it solved a 50-year-old scientific challenge that could speed drug discovery
By
Jeremy Kahn
July 15, 2021
Most Popular
Success
The scientist who helped create AI says it’s only ‘a matter of time’ before every single job is wiped out—even safer...
By
Orianna Rosa Royle
Success
As graduates face a ‘jobpocalypse,’ Goldman Sachs exec tells Gen Z they need to know their commercial impact
By
Preston Fore
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg